CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 174 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2015. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $70,000 | -43.1% | 29,992 | -30.7% | 0.00% | -100.0% |
| Q4 2017 | $123,000 | +324.1% | 43,253 | +325.0% | 0.00% | – |
| Q3 2017 | $29,000 | -31.0% | 10,176 | -2.7% | 0.00% | – |
| Q3 2016 | $42,000 | -30.0% | 10,459 | -23.1% | 0.00% | – |
| Q2 2016 | $60,000 | +27.7% | 13,600 | +10.4% | 0.00% | – |
| Q1 2016 | $47,000 | -67.1% | 12,323 | +34.8% | 0.00% | -100.0% |
| Q4 2015 | $143,000 | +12.6% | 9,143 | -24.3% | 0.00% | 0.0% |
| Q3 2015 | $127,000 | +35.1% | 12,071 | +225.5% | 0.00% | 0.0% |
| Q2 2015 | $94,000 | +14.6% | 3,709 | +26.4% | 0.00% | 0.0% |
| Q1 2015 | $82,000 | +67.3% | 2,935 | +8.4% | 0.00% | – |
| Q4 2014 | $49,000 | +16.7% | 2,708 | -16.3% | 0.00% | – |
| Q3 2014 | $42,000 | -19.2% | 3,235 | +2.4% | 0.00% | – |
| Q2 2014 | $52,000 | -7.1% | 3,160 | 0.0% | 0.00% | -100.0% |
| Q1 2014 | $56,000 | -30.0% | 3,160 | -3.9% | 0.00% | 0.0% |
| Q4 2013 | $80,000 | -78.2% | 3,287 | -68.2% | 0.00% | -66.7% |
| Q3 2013 | $367,000 | +326.7% | 10,347 | +88.5% | 0.00% | +200.0% |
| Q2 2013 | $86,000 | – | 5,489 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |